Latest news for Sweet Earth Holdings (OTC:SEHCF) Stock

Sweet Earth Holdings Corp is engaged in cultivating and processing Hemp cannabidiols. The company operates in one reportable segment, the sale of hemp pre-roll and skin care products. The company's assets are located in Spain, Canada, and the USA.

Cannabis

Penny Stocks

Small Business

Markets

Interview

SEHCF

CSE:SE

TSXV:NIM

Peter Espig, CEO of Sweet Earth (CSE: SE) (FSE: 1KZ1) (OTCQB: SEHCF) products, refers to himself as a “weekend warrior” who very much appreciates the brand’s medical benefits of CBD, CBN and CBG, the cannabinoids secreted within the resinous parts of the cannabis plant.

Sweet Earth Holdings CEO: Align Your Products With Key CBD Leaders, Especially If They&#39;re In California

SWEET EARTH HLDS CORP by Sweet Earth Holdings Corporation

Sweet Earth Holdings Corp

UBS analyst Peter Grom maintains Monster Beverage (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MNST#NASDAQ">MNST</a>) with a Neutral and lowers the price target from $57 to $53.

News

Price Target

Analyst Ratings

MNST

UBS Maintains Neutral on Monster Beverage, Lowers Price Target to $53

UBS analyst Peter Grom maintains Molson Coors Beverage (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TAP#NYSE">TAP</a>) with a Neutral and lowers the price target from $60 to $58.

UBS Maintains Neutral on Molson Coors Beverage, Lowers Price Target to $58

UBS analyst Sean King maintains Keurig Dr Pepper (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KDP#NASDAQ">KDP</a>) with a Buy and lowers the price target from $42 to $37.

UBS Maintains Buy on Keurig Dr Pepper, Lowers Price Target to $37

Biotech

General

Hims & Hers Health, Inc. Class A Common Stock

HIMS

U.S. FDA Chief Califf Says Current Regulations Not Enough To Protect Americans From Risks Of Compounded GLP-1 Drugs

UBS analyst Peter Grom maintains Coca-Cola (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KO#NYSE">KO</a>) with a Buy and lowers the price target from $82 to $72.

UBS Maintains Buy on Coca-Cola, Lowers Price Target to $72

Rio Tinto Plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RIO#NYSE">RIO</a>) and Glencore Plc (OTC:<a class="ticker" href="https://www.benzinga.com/stock/GLNCY#OTC">GLNCY</a>), two of the largest mining companies in the world, have engaged in preliminary discussions about merging their businesses. 
What To Know: <a href="https://www.bloomberg.com/news/articles/2025-01-16/rio-tinto-glencore-are-said-to-discuss-potential-combination?srnd=homepage-americas">According to Bloomberg,</a> the talks, which remain in the early stages, have not been confirmed as ongoing. Sources, who requested anonymity due to the confidentiality of the information, noted the uncertainty surrounding whether the discussions will progress further. Representatives from Rio Tinto declined to comment, while Glencore did not immediately respond to statement requests.
Shares of both companies reacted to the news. Rio Tinto&#8217;s stock dropped 2.03% during recent trading, likely reflecting investor caution surrounding the uncertainty of the talks. Meanwhile, Glencore's stock surged 7.76%, potentially driven by market optimism about the potential synergies and scale such a merger could deliver.
This development, if it progresses, could have significant implications for the global mining industry, given the combined operational reach and resource portfolio of the two firms.
Price Action: Rio Tinto shares were down 1.70% at $59.43 and Glencore PLC shares were up 5.32% at $9.53 at the time of writing, according to <a href="https://pro.benzinga.com/dashboard?new_user=False&amp;backend=google-oauth2">Benzinga Pro.</a>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/cannabis/25/01/43038294/can-ai-solve-cannabis-medicines-data-problem-new-tech-initiative-aims-to-streamline-research-and-treatments">Can AI Solve Cannabis Medicine&#8217;s Data Problem? New Tech Initiative Aims To Streamline Research And Treatments</a></li>
</ul>
Photo by solarseven on Shutterstock.

Movers

GLNCY

Rio Tinto And Glencore Weigh Historic Merger, Shaking Up Global Mining

<a href="https://abcnews.go.com/Politics/biden-administration-leave-trump-implement-tiktok-ban/story?id=117753133" title="https://abcnews.go.com/Politics/biden-administration-leave-trump-implement-tiktok-ban/story?id=117753133">https://abcnews.go.com/Politics/biden-administration-leave-trump-implement-tiktok-ban/story?id=117753133</a>

Politics

Legal

ORCL

SNAP

"The Biden Administration Doesn't Plan To Take Action That Forces TikTok To Immediately Go Dark For U.S. Users On Sunday" - ABC News

UBS analyst Peter Grom maintains Celsius Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CELH#NASDAQ">CELH</a>) with a Buy and lowers the price target from $45 to $39.

CELH

UBS Maintains Buy on Celsius Holdings, Lowers Price Target to $39

UBS analyst Sean King maintains Boston Beer Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SAM#NYSE">SAM</a>) with a Neutral and lowers the price target from $315 to $290.

UBS Maintains Neutral on Boston Beer Co, Lowers Price Target to $290

UBS analyst Peter Grom maintains YETI Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/YETI#NYSE">YETI</a>) with a Neutral and lowers the price target from $44 to $43.

YETI

UBS Maintains Neutral on YETI Holdings, Lowers Price Target to $43

The National Rifle Association warns that court rulings challenging the <a href="https://www.benzinga.com/markets/cannabis/24/06/39488414/cannabis-guns-kentucky-2nd-amendment-meet-the-atf-if-you-say-yes-to-medical-marijuana-the-answer">federal gun ban for marijuana users</a> have created a confusing legal landscape for cannabis users and gun owners alike.
While nearly <a href="https://www.benzinga.com/government/regulations/24/12/42724338/new-year-2025-how-americas-love-of-cannabis-transformed-social-life-industry-and-health-trends">half of all U.S. states</a> have some form of legal cannabis and nearly 40 states have legal medical marijuana, the NRA noted that federal law continues to prohibit the possession of both. And, a 2024 <a href="https://ammo.com/articles/how-many-gun-owners-in-america">survey</a> indicated that 32% of Americans (107 million people) reported that they personally owned a firearm.
"Marijuana use is no longer limited to the domain of indigenous religious customs or youth-oriented counterculture and now includes a wide variety of people who use it for medicinal or recreational reasons," <a href="https://www.nraila.org/articles/20250113/us-appellate-court-issues-case-on-marijuana-use-and-firearm-possession">wrote</a> the NRA in a recent blog post. "Many of these individuals are otherwise law-abiding and productive members of their communities and want to exercise their right to keep and bear arms. Yet federal law continues to ban outright the cultivation, possession, and distribution of marijuana, as well as the possession of marijuana paraphernalia."
<h2 class="wp-block-heading">Second Amendment Violations</h2>
The group cited several <a href="https://www.benzinga.com/markets/cannabis/24/08/40655441/cannabis-users-cannot-be-barred-from-gun-ownership-u-s-appeals-court-rules">court decisions</a> that ruled on the side of medical marijuana users not being put into a situation where they have to choose between their treatment and their <a href="https://constitution.congress.gov/constitution/amendment-2/">Second Amendment right</a> "to keep and bear Arms."
"Whatever position one takes on the use of marijuana, Americans deserve laws that are clear, that are consistently and fairly applied, and that comply with the U.S. Constitution, as it was understood when it was adopted and amended in relevant respects," noted the NRA.
Read Also: <a href="https://www.benzinga.com/markets/cannabis/24/08/40655441/cannabis-users-cannot-be-barred-from-gun-ownership-u-s-appeals-court-rules">Cannabis Users Cannot Be Barred From Gun Ownership, U.S. Appeals Court Rules</a>
<h2 class="wp-block-heading">What&#8217;s The Government Worried About?</h2>
The Department of Justice has long contended that <a href="https://www.benzinga.com/topic/medical-cannabis" target="_blank" rel="noreferrer noopener">medical marijuana</a> users who own firearms pose a threat to public safety, increase the risk of suicide and are more prone to committing crimes to support their "drug habit." This position underpins the <a href="https://www.benzinga.com/markets/cannabis/24/05/38681854/cannabis-and-guns-this-vet-chose-the-latter-but-he-shouldnt-have-to-now-hes-going-to-federal-cou" target="_blank" rel="noreferrer noopener">federal prohibition on gun ownership</a> by cannabis users.
<h2 class="wp-block-heading">How Are Gun Makers Faring With Fed's No-Gun &amp; Weed Laws?</h2>
Following a rise in gun purchases in the U.S. during the pandemic, sales dropped and then soon moved steadily back up. Over the past five years, online gun and ammunition sales have grown at a CAGR of 8.8% to $3.4 billion, including a 5.1% increase in 2024 alone, <a href="https://www.ibisworld.com/united-states/industry/guns-ammunition-manufacturing/662/">according</a> to IBISWorld. 
<h2 class="wp-block-heading">Gun Makers Are Holding Their Own</h2>
&#8220;The growth in e-commerce and rising disposable incomes have been pivotal in fueling revenue growth for online gun and ammunition sales,&#8221; noted IBIS, which added that the gun market is projected to grow over the next five years.
Gun manufacturers, such as Smith &amp; Wesson Brands, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SWBI#NASDAQ">SWBI</a>), Sturm, Ruger &amp; Company, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RGR#NYSE">RGR</a>) were both trading higher on Thursday – 0.69% and 0.76% respectively while American Outdoor Brands, Inc.&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AOUT#NASDAQ">AOUT</a>) is down 0.95%, Ammo, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/POWW#NASDAQ">POWW</a>) is flat and gun-related Olin Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OLN#NYSE">OLN</a>) is trading 1.22% lower.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/01/42821003/trump-jr-invests-in-grabagun-what-investors-should-know-about-ecommerce-company-set-to-trade-as-pew">Trump Jr. Partners With GrabAGun: What Investors Should Know About E-Commerce Company Set To Trade As &#8216;PEW&#8217;</a></li>
</ul>
Photo: Benzinga edit with images by&nbsp;<a href="https://unsplash.com/@sichpicsss?utm_content=creditCopyText&amp;utm_medium=referral&amp;utm_source=unsplash" target="_blank" rel="noreferrer noopener">Matthew Sichkaruk</a>&nbsp;on&nbsp;<a href="https://unsplash.com/photos/green-leaf-in-close-up-photography-eh3Sy2XQr7s?utm_content=creditCopyText&amp;utm_medium=referral&amp;utm_source=unsplash" target="_blank" rel="noreferrer noopener">Unsplash</a>&nbsp;and&nbsp;<a href="https://www.pexels.com/@pixabay/" target="_blank" rel="noreferrer noopener">Pixabay</a>&nbsp;on Pexels.

Government

Regulations

Trading Ideas

AOUT

POWW

SWBI

NRA Warns Of Legal Confusion Over Guns And Cannabis: Could Fed Ban Expand?

FTAI Aviation Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FTAI#NASDAQ">FTAI</a>) shares are trading higher Thursday, rebounding from a sharp decline following allegations in a <a href="https://www.benzinga.com/pressreleases/25/01/g43038032/ftai-aviation-ftai-shares-plummet-after-muddy-waters-report-alleges-misleading-accounting-hagens-b">report by Muddy Waters. </a>
What To Know: The report accused the company of financial misrepresentation in its Aerospace Products segment, including recording one-time engine sales as recurring Maintenance Repair &amp; Overhaul (MRO) revenue.
The January 15 report triggered a 24% drop in FTAI Aviation&#8217;s stock as investors reacted to claims of inflated revenue and channel stuffing in 2023 financial results. The allegations included input from industry insiders and a former company executive. FTAI Aviation&#8217;s third-quarter 2024 revenue in the Aerospace Products segment was $303 million, a 155% increase from last year.
The stock&#8217;s rebound potentially reflects continued momentum as the market digests the impact of the short seller's claims and ongoing legal investigations into potential violations of federal securities laws.
<h3 class="wp-block-heading">How To Buy FTAI Stock?</h3>
By now you're likely curious about how to participate in the market for FTAI Aviation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FTAI#NASDAQ">FTAI</a>) &#8211; be it to purchase shares, or even attempt to bet against the company.
Buying shares is typically done through a brokerage account. You can find a list of <a href="https://www.benzinga.com/money/best-stock-trading-platforms">possible trading platforms here.</a> Many will allow you to buy ‘fractional shares,' which allows you to own portions of stock without buying an entire share. 
In the the case of FTAI Aviation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FTAI#NASDAQ">FTAI</a>), which is trading at $127.08 as of publishing time, $100 would buy you 0.79 shares of stock.
If you're looking to bet against a company, the process is more complex. You'll need access to an options trading platform, or a broker who will allow you to ‘go short' a share of stock by lending you the shares to sell. The process of shorting a <a href="https://www.benzinga.com/money/how-to-short-a-stock">stock can be found at this resource.</a> Otherwise, if your broker allows you to trade options, you can either buy a put option, or sell a call option at a strike price above where shares are currently trading &#8211; either way it allows you to profit off of the share price decline.
FTAI Price Action: FTAI Aviation shares were up 5.55% at $122.20 at the time of writing, according to <a href="https://pro.benzinga.com/dashboard?new_user=False&amp;backend=google-oauth2">Benzinga Pro.</a>
<figure class="wp-block-image size-large is-resized"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent011625&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="1024" height="538" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/16143759/Screenshot-2025-01-16-at-14.37.32-1024x538.png" alt="" class="wp-image-737596" style="width:530px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/16143759/Screenshot-2025-01-16-at-14.37.32-1024x538.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/16143759/Screenshot-2025-01-16-at-14.37.32-300x158.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/16143759/Screenshot-2025-01-16-at-14.37.32-768x403.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/16143759/Screenshot-2025-01-16-at-14.37.32.png 1527w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/cannabis/25/01/43038294/can-ai-solve-cannabis-medicines-data-problem-new-tech-initiative-aims-to-streamline-research-and-treatments">Can AI Solve Cannabis Medicine&#8217;s Data Problem? New Tech Initiative Aims To Streamline Research And Treatments</a></li>
</ul>

Image Via Unsplash.

Short Sellers

FTAI

FTAI Aviation Shares Recover After Short Seller-Driven Decline: What To Know

UBS analyst Peter Grom maintains Spectrum Brands Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPB#NYSE">SPB</a>) with a Buy and lowers the price target from $114 to $109.

UBS Maintains Buy on Spectrum Brands Holdings, Lowers Price Target to $109

Northrop Grumman's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOC#NYSE">NOC</a>) short percent of float has fallen 4.29% since its last report. The company recently reported that it has 1.95 million shares sold short, which is 1.34% of all regular shares that are available for trading. Based on its trading volume, it would take traders 3.14 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Northrop Grumman Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1737060322_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Northrop Grumman has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Northrop Grumman's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Northrop Grumman's peer group average for short interest as a percentage of float is 3.60%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Ideas

(NOC) - Analyzing Northrop Grumman's Short Interest

Applied Optoelectronics's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AAOI#NYSE">AAOI</a>) short percent of float has fallen 12.02% since its last report. The company recently reported that it has 8.42 million shares sold short, which is 17.72% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.89 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Applied Optoelectronics Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1737060317_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Applied Optoelectronics has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Applied Optoelectronics's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Applied Optoelectronics's peer group average for short interest as a percentage of float is 6.14%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

AAOI

(AAOI) - Analyzing Applied Optoelectronics's Short Interest

High-rolling investors have positioned themselves bullish on Energy Transfer (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ET#NYSE">ET</a>), and it's important for retail traders to take note. 
\This activity came to our attention today through Benzinga's tracking of publicly available options data. The identities of these investors are uncertain, but such a significant move in ET often signals that someone has privileged information.
Today, Benzinga's options scanner spotted 11 options trades for Energy Transfer. This is not a typical pattern.
The sentiment among these major traders is split, with 81% bullish and 18% bearish. Among all the options we identified, there was one put, amounting to $25,800, and 10 calls, totaling $571,128.
<h3>Projected Price Targets</h3>
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $15.0 to $21.0 for Energy Transfer during the past quarter. 
<h3>Volume &amp; Open Interest Development</h3>
In terms of liquidity and interest, the mean open interest for Energy Transfer options trades today is 15728.6 with a total volume of 3,857.00.
In the following chart, we are able to follow the development of volume and open interest of call and put options for Energy Transfer's big money trades within a strike price range of $15.0 to $21.0 over the last 30 days.
<h3>Energy Transfer Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1737060317_0_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>ET</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$1.6</td>
<td>$1.58</td>
<td>$1.6</td>
<td>$20.00</td>
<td>$183.2K</td>
<td>36.4K</td>
<td>1.1K</td>
</tr>
<tr>
<td>ET</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/15/27</td>
<td>$2.05</td>
<td>$1.94</td>
<td>$2.05</td>
<td>$20.00</td>
<td>$80.3K</td>
<td>22.0K</td>
<td>422</td>
</tr>
<tr>
<td>ET</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$5.2</td>
<td>$5.1</td>
<td>$5.1</td>
<td>$15.00</td>
<td>$50.9K</td>
<td>3.2K</td>
<td>264</td>
</tr>
<tr>
<td>ET</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>07/18/25</td>
<td>$1.15</td>
<td>$1.07</td>
<td>$1.08</td>
<td>$20.00</td>
<td>$43.3K</td>
<td>2.3K</td>
<td>405</td>
</tr>
<tr>
<td>ET</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$2.0</td>
<td>$1.95</td>
<td>$2.0</td>
<td>$18.00</td>
<td>$40.0K</td>
<td>11.6K</td>
<td>227</td>
</tr>
</tbody>
</table>

<h3>About Energy Transfer</h3>
Energy Transfer owns one of the largest portfolios of crude oil, natural gas, and natural gas liquid assets in the US, primarily in Texas and the US midcontinent region. Its pipeline network totals 130,000 miles. It also owns gathering and processing facilities, one of the largest fractionation facilities in the US, fuel distribution assets, and the Lake Charles gas liquefaction facility. It combined its publicly traded limited and general partnerships in October 2018.
Following our analysis of the options activities associated with Energy Transfer, we pivot to a closer look at the company's own performance.
<h3>Where Is Energy Transfer Standing Right Now?</h3>
<ul>
<li>With a trading volume of 12,152,088, the price of ET is up by 0.1%, reaching $20.06.</li>
<li>Current RSI values indicate that the stock is may be overbought.</li>
<li>Next earnings report is scheduled for 26 days from now.</li>
</ul>
<h3>What The Experts Say On Energy Transfer</h3>
In the last month, 4 experts released ratings on this stock with an average target price of $22.0.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; Maintaining their stance, an analyst from Wells Fargo continues to hold a Overweight rating for Energy Transfer, targeting a price of $21. 
&#x2A; An analyst from Goldman Sachs has decided to maintain their Neutral rating on Energy Transfer, which currently sits at a price target of $20. 
&#x2A; An analyst from Barclays persists with their Overweight rating on Energy Transfer, maintaining a target price of $22. 
&#x2A; An analyst from Barclays has decided to maintain their Overweight rating on Energy Transfer, which currently sits at a price target of $25. 
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Energy Transfer with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.

Options

This Is What Whales Are Betting On Energy Transfer

Accenture (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ACN#NYSE">ACN</a>) has outperformed the market over the past 20 years by 5.62% on an annualized basis producing an average annual return of 14.08%. Currently, Accenture has a market capitalization of $218.92 billion. 
Buying $1000 In ACN: If an investor had bought $1000 of ACN stock 20 years ago, it would be worth $14,100.80 today based on a price of $350.00 for ACN at the time of writing.
<h3>Accenture's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1737060314_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$1000 Invested In Accenture 20 Years Ago Would Be Worth This Much Today

Teladoc Health's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TDOC#NYSE">TDOC</a>) short percent of float has risen 3.62% since its last report. The company recently reported that it has 23.53 million shares sold short, which is 17.76% of all regular shares that are available for trading. Based on its trading volume, it would take traders 5.71 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Teladoc Health Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1737060311_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Teladoc Health has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Teladoc Health's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Teladoc Health's peer group average for short interest as a percentage of float is 5.32%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

TDOC

Looking Into Teladoc Health's Recent Short Interest

UBS analyst Peter Grom maintains Scotts Miracle Gro (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SMG#NYSE">SMG</a>) with a Neutral and lowers the price target from $77 to $72.

UBS Maintains Neutral on Scotts Miracle Gro, Lowers Price Target to $72

UBS analyst Peter Grom maintains Reynolds Consumer Prods (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/REYN#NASDAQ">REYN</a>) with a Neutral and lowers the price target from $30 to $29.

REYN

UBS Maintains Neutral on Reynolds Consumer Prods, Lowers Price Target to $29

Sweet Earth Holdings (TSE:SE) has released an update. Sweet Earth Holdings has announced a non-brokered private placement aiming to raise up to $20...

Sweet Earth Holdings Plans New Share Placement

Sweet Earth Holdings (TSE:SE) has released an update. Sweet Earth Holdings has successfully closed a non-brokered private placement, raising $204,0...

Sweet Earth Closes Private Placement Successfully

Sweet Earth Holdings (TSE:SE) has released an update. Sweet Earth Holdings has announced a consolidation of its common shares, exchanging ten pre-c...

Sweet Earth Holdings Announces Share Consolidation

Sweet Earth Holdings (TSE:SE) has released an update. Sweet Earth Holdings is set to consolidate its common shares at a 10-to-1 ratio, effective De...

Sweet Earth Holdings to Consolidate Shares

Sweet Earth Holdings

Peter Espig, CEO of Sweet Earth (CSE:<a class="ticker" href="https://www.benzinga.com/stock/SE#CSE">SE</a>) (FSE: 1KZ1) (OTCQB:<a class="ticker" href="https://www.benzinga.com/stock/SEHCF#OTCQB">SEHCF</a>) products, refers to himself as a &ldquo;weekend warrior&rdquo; who very much appreciates the brand&rsquo;s medical benefits of CBD, CBN and CBG,&nbsp;the cannabinoids secreted within the resinous parts of the cannabis plant.

Sweet Earth is a vertically integrated &quot;farm to shelf&quot; hemp grower with grows in Applegate and Medford, Oregon. These maintain a full line of hemp and CBD products for the U.S. and global market. In July 2021, the company announced that its sales were growing both online and in retail shops.

Also recently, Sweet Earth representatives, including&nbsp;spokesperson and CFL/NFL Hall of Fame quarterback&nbsp;Warren Moon,&nbsp;appeared on Kathy Ireland&#39;s Health and Wellness Show, which is always a positive sales booster.

What makes Sweet Earth&rsquo;s CBD products different or better than the myriad brands already in the marketplace?

From a business point of view, in addition to the farm and harvesting expertise, the company chose its allies with care, Espig explained.

&ldquo;We quickly aligned ourselves with key leaders within our targeted products. For example, rather than research how to make our industry-leading hydration cream, we teamed with a top West-Coast based spa product provider. This allowed us to leverage their 20 plus years spa experience with our CBD expertise,&rdquo; Espig told Benzinga. &ldquo;We recognize that we don&rsquo;t need to play every instrument, but that every orchestra needs an effective conductor.&rdquo;

Sweet Earth, which went public in May 2020, wisely chose Espig as CEO, he assumes because of his public market experience, thus allowing the team to focus on business execution while he focuses on public market initiatives. Espig is also <a href="https://www.benzinga.com/pressreleases/21/08/22693422/nicola-mining-inc-provides-exploration-update">CEO and director of Nicola Mining Inc</a>. (TSXV:<a class="ticker" href="https://www.benzinga.com/stock/NIM#TSXV">NIM</a>) (FSE: HLI).

It also helps to have positive scientific feedback.

The company undertook a series of bioavailability studies and product development with NAVCO Pharmaceuticals Limited, a laboratory in Ontario. The study, &quot;Skin Redeemability for Body Creams&quot; tested the bioavailability, safety and efficacy of Sweet Earth&rsquo;s lotions by better understanding permeability.

&ldquo;We base our products on research and, more than our peers, spend a lot of time understanding efficacy and bioavailability of product based on micro/molecular properties and ingredient combinations,&rdquo; Espig said, adding that the company will soon be publishing a significant research paper&nbsp;highlighting the superior penetration of Sweet Earth&#39;s product vs peers and the impact of various nano-attributes of the CBD on efficacy.

Espig stressed that&nbsp;the industry needs science-based consistency at every level of product development.

&ldquo;Although there is a significant amount of research on CBD and its positive effects, it is at the university/research institute level. Generally, most CBD product producers are akin to bakers, in that they combine acceptable ingredients, without really understanding product bioavailability and ingredient-specific efficacy,&rdquo; he concluded.

Photo: Courtesy of Sweet Earth

Encuentra nuestro contenido en Espa&ntilde;ol en El Planteo:

<ul>
	<li><a href="https://elplanteo.com/ceo-hexo-empresas-canadienses-cannabis-nyse-nasdaq/">C&oacute;mo Empresas Canadienses de Cannabis Pueden Cotizar en NYSE y NASDAQ, Segun el CEO de HEXO</a></li>
	<li><a href="https://elplanteo.com/personajes-marihuana-peliculas/">C&oacute;mo Avanz&oacute; la Representaci&oacute;n de lxs Consumidores de Marihuana en las Pel&iacute;culas</a></li>
</ul>

Comments

Sweet Earth Holdings

News

Latest news for Sweet Earth Holdings (OTC:SEHCF) Stock

Monday, August 30, 2021

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga